Synchron Secures $200 Million in Series D Funding to Develop Brain-Computer Interface Technology
Synchron has raised $200 million in a Series D funding round to accelerate the commercialization of its Stentrode™ brain-computer interface (BCI) platform. This investment will also support the expansion of the company's artificial intelligence and engineering teams in both New York and San Diego.
Key Details
- Funding amount: $200 million
- Purpose: Commercialize the Stentrode™ BCI platform
- Expansion: AI and engineering operations in New York and San Diego
Photo credit: Synchron
Contact Information
Media Contact: Kimberly Ha
Email: [email protected]
"Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego."
Summary: Synchron’s significant $200 million funding round supports its mission to bring advanced brain-computer interface technology to market while growing its AI and engineering capabilities.